Latest On Quanterix Corporation (QTRX):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2023-05-23 16:53 EST | News | Quanterix at one-year high as Goldman upgrades on neuro opportunity | N/A |  |
| 2023-05-13 19:52 EST | News | Quanterix Corporation (QTRX) Q1 2023 Earnings Call Transcript | N/A | |
| 2023-05-09 17:32 EST | News | Quanterix GAAP EPS of -$0.16 beats by $0.22, revenue of $28.5M beats by $3.1M | N/A | |
| 2023-05-09 03:37 EST | News | Quanterix Q1 2023 Earnings Preview | N/A | |
| 2023-03-18 04:32 EST | News | Quanterix (QTRX) presents at Barclays Global Healthcare Conference - Slideshow | N/A | |
About Quanterix Corporation (QTRX):
Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assay kits and other consumables such as reagents. In addition, it offers contract research services, including sample testi read more...ng, homebrew assay development, and custom development services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct sales force, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
General
- Name Quanterix Corporation
- Symbol QTRX
- Type Common Stock
- Exchange NASDAQ
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Full Time Employees 314
- Fiscal Year EndDecember
- IPO Date2017-12-07
- Gic SectorHealth Care
- Gic GroupPharmaceuticals, Biotechnology & Life Sciences
- Gic IndustryLife Sciences Tools & Services
- Gic SubIndustryLife Sciences Tools & Services
- Web URLhttp://www.quanterix.com
Valuation
- Price/Sales (Trailing 12 Mt.) 21.43
- Price/Book (Most Recent Quarter) 11.01
- Enterprise Value Revenue 24.52
Financials
- Most Recent Quarter 2020-12-31
- Current Year EPS Estimate -$1.27
- Next Year EPS Estimate -$0.89
- Next Quarter EPS Estimate -$0.30
- Profit Margin -37%
- Operating Margin -36%
- Return on Assets -9%
- Return on Equity -19%
- Revenue 86.38 million
- Earnings Per Share -$1.64
- Revenue Per Share $2.92
- Gross Profit 48.9 million
- Quarterly Earnings Growth 64.2%
Highlights
- Market Capitalization 2.1 billion
- EBITDA -34630000
- PE Ratio -12.59
- Analyst Target Price $89
- Book Value Per Share $6.48
Share Statistics
- Shares Outstanding 36.27 million
- Shares Float 30.39 million
- % Held by Insiders 804%
- % Held by Institutions 85.76%
- Shares Short 602607
- Shares Short Prior Month 497114
- Short Ratio 1.26
- Short % of Float 3%
- Short % of Shares Outstanding 2%
Technicals
- Beta 1.64
- 52 Week High $92.57
- 52 Week Low $13.36
- 50 Day Moving Average 72.84
- 200 Day Moving Average 51.74
Dividends
- Dividend Date N/A
- ExDividend Date N/A
- Dividend Yield 0%
Quanterix Corporation (QTRX) Dividend Calendar:
Quanterix Corporation (QTRX) Earnings History:
Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.
Quanterix Corporation (QTRX) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date |
|---|
| Research Development |
| Income Before Tax |
| Selling General Administrative |
| Gross Profit |
| Ebit |
| Operating Income |
| Income Tax Expense |
| Total Revenue |
| Cost of Revenue |
| Total Other Income Expense Net |
| Net Income From Continuing Operations |
| Net Income Applicable to Common Shares |
Cash Flow:
| Date |
|---|
| Investments |
| Change to Liabilities |
| Total Cash Flow from Investing Activities |
| Net Borrowings |
| Total Cash Flow from Financial Activities |
| Change to Operating Activities |
| Change in Cash |
| Total Cash from Operating Activities |
| Depreciation |
| Other Cash Flow from Investing Activities |
| Change to Inventory |
| Change to Account Receivables |
| Other Cash Flow from Financing Activities |
| Change to Net Income |
| Capital Expenditures |
Balance Sheet:
| Date |
|---|
| Total Liabailities |
| Total Stockholder Equity |
| Other Current Liabilities |
| Total Assets |
| Common Stock |
| Other Current Assets |
| Retained Earnings |
| Other Liabilities |
| Other Assets |
| Cash |
| Total Current Liabilities |
| Other Stockholder Equity |
| Property, Plant & Equipment |
| Total Current Assets |
| Long Term Investments |
| Net Tangible Assets |
| Short Term Investments |
| Long Term Debt |
| Inventory |
| Accounts Payable |
Quanterix Corporation (QTRX) Chart:
Quanterix Corporation (QTRX) News:
Below you will find a list of latest news for Quanterix Corporation (QTRX) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
Quanterix Corporation (QTRX) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
Latest QTRX Trades:
Quanterix Corporation (QTRX) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | View |
|---|---|---|
| 2020-11-06 | S-3ASR (Automatic shelf registration statement of securities of well-known seasoned issuers) | |
| 2020-11-06 | 10-Q (Quarterly report [Sections 13 or 15(d)]) | |
| 2020-11-06 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-05 | 8-K (Current report) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-11-03 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-20 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-20 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-15 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-08 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 8-K (Current report) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-05 | 4 (Statement of changes in beneficial ownership of securities) | |
| 2020-10-02 | 4 (Statement of changes in beneficial ownership of securities) | |
Quanterix Corporation (QTRX) Insider Transactions:
Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Quanterix Corporation (QTRX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 804%
Institutional Ownership: 8576%
| Transaction Date | Insider Name | Insider Title | Type | Shares Number | Shares Price | Total Transaction | Shares Held After Transaction | Link |
|---|---|---|---|---|---|---|---|---|
| 2020-11-05 | Martin D Madaus | Director | Sell | 1,372.00 | 42.45 | 58,241.40 | 11,716.00 | |
| 2020-11-05 | Martin D Madaus | Director | Buy | 1,372.00 | 2.28 | 3,128.16 | 13,088.00 | |
| 2020-11-04 | Martin D Madaus | Director | Sell | 1,600.00 | 39.40 | 63,040.00 | 11,716.00 | |
| 2020-11-04 | Martin D Madaus | Director | Buy | 1,600.00 | 2.28 | 3,648.00 | 13,316.00 | |
| 2020-11-02 | E KEVIN HRUSOVSKY | Chairman, President & CEO | Sell | 3,264.00 | 36.97 | 120,665.84 | 1,028,534.00 | |
| 2020-11-02 | Mark T. Roskey | SVP, Commercial & Accelerator | Sell | 91.00 | 36.97 | 3,364.15 | 21,188.00 | |
| 2020-11-02 | Amol Chaubal | Chief Financial Officer | Sell | 116.00 | 36.97 | 4,288.37 | 25,261.00 | |
| 2020-11-02 | John J Fry | General Counsel & Secretary | Sell | 142.00 | 36.97 | 5,249.56 | 31,085.00 | |
| 2020-11-02 | Dawn Mattoon | Sr. VP, Research Products | Sell | 159.00 | 36.97 | 5,878.02 | 31,344.00 | |
| 2020-10-29 | E KEVIN HRUSOVSKY | Chairman, President & CEO | Sell | 2,000.00 | 38.30 | 76,600.00 | 1,031,798.00 | |
| 2020-10-20 | Martin D Madaus | Director | Sell | 1,600.00 | 42.57 | 68,112.00 | 11,716.00 | |
| 2020-10-20 | Martin D Madaus | Director | Buy | 1,600.00 | 2.28 | 3,648.00 | 13,316.00 | |
| 2020-10-19 | Martin D Madaus | Director | Sell | 1,600.00 | 44.59 | 71,344.00 | 11,716.00 | |
| 2020-10-19 | Martin D Madaus | Director | Buy | 1,600.00 | 2.28 | 3,648.00 | 13,316.00 | |
| 2020-10-16 | David C. Duffy | SVP R&D and CTO | Sell | 1,667.00 | 43.04 | 71,747.68 | 42,844.00 | |
| 2020-10-13 | E KEVIN HRUSOVSKY | Chairman, President & CEO | Sell | 2,000.00 | 44.49 | 88,980.00 | 1,033,798.00 | |
| 2020-10-07 | Martin D Madaus | Director | Sell | 1,600.00 | 37.17 | 59,472.00 | 11,716.00 | |
| 2020-10-07 | Martin D Madaus | Director | Buy | 1,600.00 | 2.28 | 3,648.00 | 13,316.00 | |
| 2020-10-06 | Martin D Madaus | Director | Sell | 1,600.00 | 36.47 | 58,356.96 | 11,716.00 | |
| 2020-10-06 | Martin D Madaus | Director | Buy | 1,600.00 | 2.28 | 3,648.00 | 13,316.00 | |